# The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

> **NCT02057263** · PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 28 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Alendronate
- **DRUG:** Hepatitis B Vaccine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02057263
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2016-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02057263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02057263, "The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02057263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*